Skip to main content
. 2024 Sep 27;10:178. doi: 10.1038/s41531-024-00789-w

Fig. 1. Participant Flowchart.

Fig. 1

1Not evaluable = CSF samples not available for alpha-synuclein aggregation testing 2Evaluable = CSF samples analyzed for alpha-synuclein aggregation and results available 3NSD = Individuals with positive alpha-synuclein aggregation tests (S + ) 4Not stageable = Missing DaT-SPECT or clinical data and unable to assess stages 5Not NSD = Individuals with negative alpha-synuclein aggregation tests (S-) NSD Neuronal Synuclein Disease.